Development of varicella vaccine

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Takahashi, Michiaki ^a,f   Asano, Yoshizo ^c,g   Kamiya, Hitoshi ^d,h   Baba, Koichi ^b,i   Ozaki, Takao ^e   Otsuka, Terumasa ^f   Yamanishi, Koichi ^a,j  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c CHUKYO HOSPITAL   (Japan)

^d MIE UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Osaka University   (Japan)

^g FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h MIE NATIONAL HOSPITAL   (Japan)

ⁱ Private Pediatric Clinic   (Japan)

^j National Center for Biomedical Innovation   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTINEOPLASTIC AGENT; CHICKENPOX VACCINE; OKA VARICELLA VACCINE; PHYTOHEMAGGLUTININ; STEROID; TUBERCULIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBODY TITER; CANCER CHEMOTHERAPY; CHICKENPOX; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIPLOIDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEVER; FOLLOW UP; HERPES ZOSTER; HUMAN; LEUKEMIA REMISSION; LYMPHOBLASTOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PAPULE; PRIORITY JOURNAL; RASH; VACCINATION; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VIREMIA; VIRUS STRAIN;

ANIMALS; CELLS, CULTURED; CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; GUINEA PIGS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; INFANT; MALE; TREATMENT OUTCOME; VIRUS LATENCY;

EID: 42549138373     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522132     Document Type: Conference Paper

References (19)

1. Takahashi M, Yamanishi K. Transformation of hamster and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. Virology 1974; 61:306-11.
2. Gelb LD, Huang JJ, Wellinghoff WJ. Varicella-zoster virus transformation of hamster embryo cells. J Gen Virol 1980; 51:171-7.
3. Gelb L, Dohner D. Varicella-zoster virus-induced transformation of mammalian cells in vitro. J Invest Dermatol 1984; 83(Suppl 1):77S-81S.
4. Taylor-Robinson D, Caunt A. Varicella virus. In: Hallauer GS, Meyer KF, eds. Virology [monograph]. Vienna and New York: Springer-Verlag, 1972: 1-88.
5. Bruusgaard E. The mutual relation between zoster and varicella. Brit J Dermatol Syph 1932; 44:1-24.
6. Greenthal RM. The prophylaxis of varicella with vesicle fluid. Am J Dis Child 1926; 31:851-5.
7. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2:1288-90.
8. Asano Y, Nakayama H, Yazaki T, et al. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977; 59:3-7.
9. Asano Y, Nakayama H, Yazaki T, et al. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics 1977; 59:8-12.
10. Asano Y, Takahashi M. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics 1977; 60:810-4.
11. Baba K, Yabuuchi H, Okuni H, Takahashi M. Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test. Pediatrics 1978; 61:550-5.
12. Kamiya H, Ihara T, Hattori A, et al. Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis 1977; 136:784-8.
13. Ha K, Baba K, Ikeda T, Nishida M, Yabuuchi H, Takahashi M. Application of a live varicella vaccine in children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics 1980; 65:346-50.
14. Izawa T, Ihara T, Hattori A, et al. Application of a live varicella vaccine in children with acute leukemia or other malignant diseases. Pediatrics 1977; 60:805-9.
15. Asano Y, Itakura N, Hiroishi Y, et al. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine. J Infect Dis 1985; 152:863-8.
16. Takahashi M, Baba K, Horiuchi K, Kamiya H, Asano Y. A live varicella vaccine. In: Lopez C, Mori R, Roizman B, Whitley RT, eds. Proceedings of the 4th International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections (Fukuoka, Japan). Adv Exp Med Biol 1990; 278:49-58.
17. Gomi Y, Imagawa T, Takahashi M, Yamanishi K. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses. Arch Virol Suppl 2001; 17:49-56.
18. Gershon A. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis 1995; 10:93-124.
19. Hardy IB, Gershon A, Steinberg S, et al. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med 1991; 325:1545-50.